◆英語タイトル：iCo Therapeutics Inc. (ICO) - Financial and Strategic SWOT Analysis Review
iCo Therapeutics Inc. (iCo) is a pharmaceutical company. The company develops and commercializes drug candidates for treating ocular and systemic fungal diseases. Its products include iCo-007, iCo-008 and Oral AmpB Delivery System. iCo’s Oral AmpB Delivery System is a proprietary oral formulation of amphotericin B for treatment of systemic fungal infections in immunocompromised patients such as human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), cancer, transplant recipients, diabetics and some parasitic infections. The company’s iCo-008 is a human monoclonal antibody targeting eotaxin-1. Its iC0-007 is a new generation antisense candidate used for treatment of diabetic macular edema. iCo is headquartered in Vancouver, British Columbia, Canada.
iCo Therapeutics Inc. Key Recent Developments
Dec 20, 2013: iCo Therapeutics Begins Trading on the OTCQX Marketplace
Dec 12, 2013: iCo Therapeutics Announces Program and Intellectual Property Advancements for Oral Amphotericin B
Dec 05, 2013: iCo Therapeutics To Present At Jefferies Ophthalmic Therapeutic Summit
Nov 27, 2013: iCo Therapeutics Announces Third Quarter 2013 Financial Results
Nov 21, 2013: iCo Therapeutics to Present at the 6th Annual LD MICRO Conference
This comprehensive SWOT profile of iCo Therapeutics Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of iCo Therapeutics Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
iCo Therapeutics Inc. – Key Information
iCo Therapeutics Inc. – Overview
iCo Therapeutics Inc. – Key Employees
iCo Therapeutics Inc. – Key Employee Biographies
iCo Therapeutics Inc. – Key Operational Heads
iCo Therapeutics Inc. – Major Products and Services
iCo Therapeutics Inc. – History
iCo Therapeutics Inc. – Company Statement
iCo Therapeutics Inc. – Locations And Subsidiaries
iCo Therapeutics Inc. – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
iCo Therapeutics Inc. – Business Description
iCo Therapeutics Inc. – Corporate Strategy
iCo Therapeutics Inc. – SWOT Analysis
SWOT Analysis – Overview
iCo Therapeutics Inc. – Strengths
iCo Therapeutics Inc. – Weaknesses
iCo Therapeutics Inc. – Opportunities
iCo Therapeutics Inc. – Threats
iCo Therapeutics Inc. – Key Competitors
Section 3 – Company Financial Performance Charts
iCo Therapeutics Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
iCo Therapeutics Inc., Key Information
iCo Therapeutics Inc., Key Ratios
iCo Therapeutics Inc., Share Data
iCo Therapeutics Inc., Major Products and Services
iCo Therapeutics Inc., History
iCo Therapeutics Inc., Key Employees
iCo Therapeutics Inc., Key Employee Biographies
iCo Therapeutics Inc., Key Operational Heads
iCo Therapeutics Inc., Other Locations
iCo Therapeutics Inc., Subsidiaries
iCo Therapeutics Inc., Key Manufacturing facilities
iCo Therapeutics Inc., Key Competitors
iCo Therapeutics Inc., SWOT Analysis
iCo Therapeutics Inc., Ratios based on current share price
iCo Therapeutics Inc., Annual Ratios
iCo Therapeutics Inc., Interim Ratios
Capital Market Ratios
List of Figures
iCo Therapeutics Inc., Performance Chart
iCo Therapeutics Inc., Ratio Charts
| ★海外企業調査レポート[iCo Therapeutics Inc. (ICO)：企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら